BIOMAT Database Logo BIOMAT Database Logo

Beta-blockers and the kidney. 1982

M Epstein, and J R Oster

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009248 Nadolol A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for MIGRAINE DISORDERS and for tremor. Corgard,SQ-11725,Solgol,SQ 11725,SQ11725
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D012079 Renal Circulation The circulation of the BLOOD through the vessels of the KIDNEY. Kidney Circulation,Renal Blood Flow,Circulation, Kidney,Circulation, Renal,Blood Flow, Renal,Flow, Renal Blood
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive

Related Publications

M Epstein, and J R Oster
Beta blockers in the management of chronic kidney disease.
December 2006, Kidney international,
M Epstein, and J R Oster
[RAAS blockers and beta blockers].
November 2011, Nihon rinsho. Japanese journal of clinical medicine,
M Epstein, and J R Oster
Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease.
January 2014, International journal of hypertension,
M Epstein, and J R Oster
Role for beta-blockers in the management of diabetic kidney disease.
September 2003, American journal of hypertension,
M Epstein, and J R Oster
Beta-blockers for coronary heart disease in chronic kidney disease.
July 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M Epstein, and J R Oster
The eye and beta-blockers.
November 1977, Lancet (London, England),
M Epstein, and J R Oster
Beta blockers and the neutrophil.
February 1987, The Journal of laboratory and clinical medicine,
M Epstein, and J R Oster
Beta-blockers and the elderly.
June 1983, Journal of clinical and hospital pharmacy,
M Epstein, and J R Oster
[Beta blockers and the skin].
November 1982, Harefuah,
M Epstein, and J R Oster
[The beta-blockers and anesthesia].
October 1977, L' Information dentaire,
Copied contents to your clipboard!